Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

bloomberg.com - Ashleigh Furlong - UK Minister Defends US Pharma Deal Following Calls to Scrap It
UK Minister Defends US Pharma Deal Following Calls to Scrap It
Bloomberg

A trade deal with the US that increases the price Britain pays for new medicines will help patients and not cause hundreds of thousands of additional deaths, according to UK Technology Secretary Liz Kendall. Kendall said an analysis published last…

marketbeat.com - Catalyst Pharmaceuticals Stockholders Clear Angelini Pharma Merger
Catalyst Pharmaceuticals Stockholders Clear Angelini Pharma Merger
MarketBeat

2 Biotechs Making Waves With A Single Product in their Pipeline Catalyst Pharmaceuticals NASDAQ: CPRX stockholders approved the company's proposed merger with Angelini Pharma S.p.A. at a special meeting held virtually on July 8, according to…

marketbeat.com - Urogen Pharma (NASDAQ:URGN) Insider Mark Schoenberg Sells 10,000 Shares
Urogen Pharma (NASDAQ:URGN) Insider Mark Schoenberg Sells 10,000 Shares
MarketBeat

Urogen Pharma (NASDAQ:URGN - Get Free Report) insider Mark Schoenberg sold 10,000 shares of the company's stock in a transaction that occurred on Thursday, July 9th. The shares were sold at an average price of $40.00, for a total value of…

marketbeat.com - BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Average Recommendation of 'Moderate Buy' by Brokerages
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Average Recommendation of 'Moderate Buy' by Brokerages
MarketBeat

Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) have been given an average recommendation of 'Moderate Buy' by the twenty-four research firms that are presently covering the company, MarketBeat reports. One equities research…

wsj.com - Health Care Roundup: Market Talk
Health Care Roundup: Market Talk
Wall Street Journal

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 1622 GMT – The failure of Wainua, a heart disease drug developed by AstraZeneca and Ionis, to meet a…

rediff.com - Rediff News - Markets surge in early trade, Sensex up by 800 pts
Markets surge in early trade, Sensex up by 800 pts
Rediff.com

Stock market benchmark indices Sensex and Nifty surged in early trade on Friday, driven by a rally in IT firms after TCS reported an increase in its June-quarter net profit and guided towards an improvement in demand returning in the ongoing…

marketwatch.com - Health Care Down on Rotation Back to Tech - Health Care Roundup
Health Care Down on Rotation Back to Tech - Health Care Roundup
MarketWatch

Health-care companies fell as traders rotated back into risky sectors. The Food and Drug Administration approved a combination treatment by Merck & Co., Pfizer, and Astellas Pharma for a hard-to-treat form of bladder cancer. Shares of obesity drug…

rediff.com - Nandita Malik - Sensex, Nifty Surge: Reliance, IT Stocks Drive Market Rally Amid Easing Crude Prices
Sensex, Nifty Surge: Reliance, IT Stocks Drive Market Rally Amid Easing Crude Prices
Rediff.com

Indian benchmark indices Sensex and Nifty extended their winning streak for a second day, with the Sensex soaring over 800 points, fuelled by strong performances from key heavyweights, easing crude oil prices, and positive earnings reports from the…

cnbc.com - Jeff Marks - The Club's top 10 things to watch in the stock market Friday
The Club's top 10 things to watch in the stock market Friday
CNBC

Our top 10 things to watch on Friday, July 10 1. S & P futures are flat on Friday morning, but the broad-based index is on pace for a weekly gain. Stocks rallied on Thursday after President Donald Trump said Iran had called to make a deal. Despite…

marketwatch.com - Merck, Pfizer, Astellas Bladder Cancer Treatment Approved by FDA
Merck, Pfizer, Astellas Bladder Cancer Treatment Approved by FDA
MarketWatch

The Food and Drug Administration approved a combination treatment by Merck & Co., Pfizer, and Astellas Pharma for a hard-to-treat form of bladder cancer. The agency greenlit Merck's Keytruda and its subcutaneous formulation Keytruda QLEX, together…

rediff.com - Nandita Malik - Indian Stock Market Surges: Sensex Jumps 700 Points on IT Sector Rally, TCS Q1 Results
Indian Stock Market Surges: Sensex Jumps 700 Points on IT Sector Rally, TCS Q1 Results
Rediff.com

Indian stock markets witnessed a robust surge in early trade, with the Sensex jumping nearly 700 points, as IT sector stocks rallied following strong June-quarter results from TCS and positive global market cues. Indian benchmark indices Sensex and…

rediff.com - Rediff News - BSE Sensex: Top gainers today
BSE Sensex: Top gainers today
Rediff.com

From the Sensex pack, Reliance Industries, Tech Mahindra, Bharat Electronics, Axis Bank, Tata Steel and Infosys were among the major winners. TCS ended 1 per cent higher after the country's largest IT services company on Thursday reported a 4.61…

seekingalpha.com - AllianceBernstein (AB) - Healthcare Investing: Finding Growth Beyond Pharmaceuticals
Healthcare Investing: Finding Growth Beyond Pharmaceuticals
Seeking Alpha

Investors are often drawn to healthcare for its innovation and long-term growth potential. From new surgical technologies to life-saving treatments, healthcare companies produce some of the economy's most exciting advancements. We believe…

thehindu.com - Pti - Markets rally for second day; Sensex jumps over 800 points
Markets rally for second day; Sensex jumps over 800 points
The Hindu

Stock market benchmark indices Sensex and Nifty ended 1% higher on Friday (July 10, 2026), taking their winning run to the second day, helped by a rally in heavyweights Reliance Industries, ICICI Bank and HDFC Bank. Easing crude oil prices and…

washingtonexaminer.com - David Harsanyi - AOC should thank baby boomers for the world they left her
AOC should thank baby boomers for the world they left her
Washington Examiner

Politicians forever exaggerate our misfortunes to gain power. But few have ever peddled this level of doomerism. Virtually the entire case of the American socialist is based on a myth. Historical context isn't always relevant to the average…

Receive a Daily briefing on Pharma Industry News

Get Started